Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Kavanagh

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Gynecologic Oncology|January 1, 1990
Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literatureG Baiocchi, J J Kavanagh, J T Wharton
European Journal of Applied Physiology|April 14, 2005
Coordination of head and trunk accelerations during walkingJ J Kavanagh, S Morrison, R S Barrett
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozoleX Wang, S Tangjitgamol, J Liu, et al.
Annals of the Academy of Medicine, Singapore|January 27, 1999
Topoisomerase-I inhibitors in gynaecologic tumoursC F Verschraegen, A P Kudelka, J J Kavanagh
European Journal of Cancer & Clinical Oncology|September 1, 1985
Phase I study of fludarabine (2-fluoro-ara-AMP)J J Kavanagh, I H Krakoff, G P Bodey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancerJ J Kavanagh, W Roberts, P Townsend, et al.
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan in cervical cancerJ J Kavanagh, C F Verschraegen, A P Kudelka
Cancer Treatment Reports|May 1, 1987
Continuous-infusion vinblastine for treatment of refractory adenocarcinoma of the cervixJ J Kavanagh, L Copeland, D Gershenson, et al.
Cancer Treatment Reports|May 1, 1987
Androgen therapy in the treatment of refractory epithelial ovarian cancerJ J Kavanagh, J T Wharton, W S Roberts
Cancer Treatment Reports|November 1, 1984
Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trialJ J Kavanagh, J T Wharton, F N Rutledge
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|January 1, 1990
Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literatureG Baiocchi, J J Kavanagh, J T Wharton
European Journal of Applied Physiology|April 14, 2005
Coordination of head and trunk accelerations during walkingJ J Kavanagh, S Morrison, R S Barrett
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozoleX Wang, S Tangjitgamol, J Liu, et al.
Annals of the Academy of Medicine, Singapore|January 27, 1999
Topoisomerase-I inhibitors in gynaecologic tumoursC F Verschraegen, A P Kudelka, J J Kavanagh
European Journal of Cancer & Clinical Oncology|September 1, 1985
Phase I study of fludarabine (2-fluoro-ara-AMP)J J Kavanagh, I H Krakoff, G P Bodey
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancerJ J Kavanagh, W Roberts, P Townsend, et al.
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan in cervical cancerJ J Kavanagh, C F Verschraegen, A P Kudelka
Cancer Treatment Reports|May 1, 1987
Continuous-infusion vinblastine for treatment of refractory adenocarcinoma of the cervixJ J Kavanagh, L Copeland, D Gershenson, et al.
Cancer Treatment Reports|May 1, 1987
Androgen therapy in the treatment of refractory epithelial ovarian cancerJ J Kavanagh, J T Wharton, W S Roberts
Cancer Treatment Reports|November 1, 1984
Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trialJ J Kavanagh, J T Wharton, F N Rutledge
Pageof 19